PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Hyperlipidemias D006949 73 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Coronary Disease D003327 70 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Weight Loss D015431 56 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Asthma D001249 52 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Precancerous Conditions D011230 48 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Leukemia P388 D007941 43 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Förstermann U et al. Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2. 1985 Prostaglandins Leukot Med pmid:2991946
Hamid S and Whittle BJ Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. 1985 Br. J. Pharmacol. pmid:2992652
Narumiya S and Toda N Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. 1985 Br. J. Pharmacol. pmid:2992661
Bertelé V et al. Refractoriness of platelets to prostaglandins after infusion in rabbits. 1985 J. Lab. Clin. Med. pmid:2997353
Thompson NT and Scrutton MC Intracellular calcium fluxes in human platelets. 1985 Eur. J. Biochem. pmid:3918866
Watanabe K et al. Biosynthesis of prostaglandin F2 alpha from prostaglandins H2 and D2 by an apparently homogeneous enzyme. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936081
Liston TE et al. Prostaglandin D2 is metabolized in humans to 9 alpha,11 beta-prostaglandin F2, a novel biologically active prostaglandin. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936123
Toda N et al. Neuroeffector actions of prostaglandins on isolated arteries. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936153
Ueno R et al. Prostaglandin D2: a cerebral sleep-regulating substance in rats. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936173
Urade Y et al. Purification and characterization of rat brain prostaglandin D synthetase. 1985 J. Biol. Chem. pmid:3930495
Schick B and Austen KF Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1985 Immunology pmid:3935569
Orchard MA et al. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma. 1985 Thromb. Res. pmid:3936223
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Cutler LS et al. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2. 1985 Biochim. Biophys. Acta pmid:3890960
Siegl PK and Wenger HC Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. 1985 Eur. J. Pharmacol. pmid:3899681
Regulatory control and standardization of allergenic extracts. Clinical studies with "standardized" extracts. 1985 Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M pmid:3901924
McGuire JC et al. Production of prostaglandin D2 by murine macrophage cell lines. 1985 Prostaglandins pmid:3937182
Lad PM et al. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. 1985 Biochim. Biophys. Acta pmid:2411298
Finney MJ et al. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. 1985 Br. J. Pharmacol. pmid:2411319
Fowler JC et al. Prostaglandins block a Ca2+-dependent slow spike afterhyperpolarization independent of effects on Ca2+ influx in visceral afferent neurons. 1985 Brain Res. pmid:2412652
Levi-Schaffer F et al. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. 1985 J. Immunol. pmid:2413121
Forman MB et al. Increased adventitial mast cells in a patient with coronary spasm. 1985 N. Engl. J. Med. pmid:2413358
Togias AG et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. 1985 J. Clin. Invest. pmid:2414318
Robin JL et al. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. 1985 J. Immunol. pmid:3161947
Schulman ES and Anderson CL Lung hypersensitivity responses: dissociation of human lung mast cell leukotriene C4 (LTC4) from histamine release. 1985 Prog. Clin. Biol. Res. pmid:2415994
Creticos PS et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. 1985 J. Clin. Invest. pmid:2416777
Holgate ST et al. The release and role of inflammatory mediators in asthma. 1985 Clin Immunol Rev pmid:2417772
Hollingsworth EB and Patrick GA The effects produced by prostaglandin D2 on serotonin turnover and release and tryptophan uptake. 1985 Pharmacol. Biochem. Behav. pmid:2581275
Fox CC et al. Isolation and characterization of human intestinal mucosal mast cells. 1985 J. Immunol. pmid:2582045
Naclerio RM et al. Inflammatory mediators in late antigen-induced rhinitis. 1985 N. Engl. J. Med. pmid:2582257
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Gause GE et al. Hemodynamic effects of postpulmonary administration of prostaglandin D2 in fetal animals. 1985 Proc. Soc. Exp. Biol. Med. pmid:3858885
Seregi A et al. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. 1985 Brain Res. pmid:3859353
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Arisawa M et al. Suppressive effect of prostaglandin D2 on prolactin secretion from rat anterior pituitary. 1985 Asia Oceania J Obstet Gynaecol pmid:3860198
Spannhake EW et al. Influence of mediators of anaphylaxis on collateral ventilation and the lung periphery of the dog. 1985 J. Pharmacol. Exp. Ther. pmid:3860642
Liston TE and Roberts LJ Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. 1985 Proc. Natl. Acad. Sci. U.S.A. pmid:3862115
Tanaka H et al. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells. 1985 Prostaglandins pmid:3863195
Liston TE and Roberts LJ Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. 1985 J. Biol. Chem. pmid:3863815
Roberts LJ and Sweetman BJ Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. 1985 Prostaglandins pmid:3864190
Banks RO and Jacobson ED Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists. 1985 Am. J. Physiol. pmid:2866716
Costall B et al. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent. 1985 Br. J. Pharmacol. pmid:3862460
Watanabe Y et al. Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. 1985 Brain Res. pmid:2994820
Ichikawa A et al. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004152
Bhattacharya SK and Parmar SS Prostaglandin D2-induced potentiation of hexobarbitone hypnosis in rats: role of 5-hydroxytryptamine. 1985 J. Pharm. Pharmacol. pmid:2868104
Whittle BJ et al. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets. 1985 Adv. Exp. Med. Biol. pmid:2871707
Nolan PN et al. Participation of prostanoids in chemical activation of the pericardial pressor reflex in dogs. 1985 Jan-Feb Clin. Exp. Pharmacol. Physiol. pmid:3924453
Korbut R and Gryglewski RJ Anti-aggregatory prostanoids. Part I. 1985 Sep-Dec Acta Physiol Pol pmid:3915631
Holgate ST The role of mast cells in the pathogenesis of asthma. 1985 Sep-Oct Bull Eur Physiopathol Respir pmid:2415192
Frölich JC et al. Advances in the analysis of eicosanoids by ELISA and GC/MS/MS. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949561
Nordlund JJ et al. Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse. 1986 J. Invest. Dermatol. pmid:3528310
Viganò T et al. Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma "in vitro". 1986 Prostaglandins Leukot Med pmid:3020580
Burrall B and Ziboh VA Increased biosynthesis of lipoxygenase products by UVB-irradiated guinea pig epidermis: evidence of a cyclooxygenase inhibitor. 1986 J. Invest. Dermatol. pmid:3086462
Koshihara Y and Kawamura M Inhibitory effect of prostaglandin D2 on DNA synthesis in nuclei. 1986 Prostaglandins Leukot Med pmid:3020589
Halenda SP et al. Effects of thrombin, phorbol myristate acetate and prostaglandin D2 on 40-41 kDa protein that is ADP ribosylated by pertussis toxin in platelets. 1986 FEBS Lett. pmid:3015684
Todo S et al. Cell kinetic studies of PGD2 cytotoxicity on the in vitro growth of human neuroblastoma. 1986 Prostaglandins Leukot Med pmid:3016753
Bhattacharya SK The antinociceptive effect of intracerebroventricularly administered prostaglandin D2 in the rat. 1986 Psychopharmacology (Berl.) pmid:3016786
Hamid-Bloomfield S and Whittle BJ Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets. 1986 Br. J. Pharmacol. pmid:3017497
Shalit M et al. New role for heparan sulfate: regulator of leukotriene generation in mouse E-mast cells. 1986 Life Sci. pmid:3018403
Kuno S et al. Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3010301
MacIntyre DE et al. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators. 1986 Agents Actions Suppl. pmid:3028106
Tanaka A et al. Antiherpetic action of prostaglandin D2. 1986 Prostaglandins Leukot Med pmid:3029784
Peters SP et al. Mediator release from human lung under conditions of reduced oxygen tension. 1986 J. Pharmacol. Exp. Ther. pmid:2425080
MacDermot J Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo. 1986 Biochem. Pharmacol. pmid:2427086
Heavey DJ et al. Prostaglandin D2 and histamine release in cold urticaria. 1986 J. Allergy Clin. Immunol. pmid:2428856
Eady RP The pharmacology of nedocromil sodium. 1986 Eur J Respir Dis Suppl pmid:2429854
Kleeberger SR et al. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. 1986 J. Appl. Physiol. pmid:2430928
Wells E et al. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. 1986 J. Immunol. pmid:2431049
Ashby B Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes. 1986 J Cyclic Nucleotide Protein Phosphor Res pmid:2432105
Koro O et al. Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. 1986 Br. J. Dermatol. pmid:2432916
Watanabe K [PGF synthetase]. 1986 Seikagaku pmid:3084680
Kriseman T et al. Analysis of airway responses to A23187 in the cat. 1986 J. Pharmacol. Exp. Ther. pmid:3095538
Eling TE et al. Oxidation of glutathione to its thiyl free radical metabolite by prostaglandin H synthase. A potential endogenous substrate for the hydroperoxidase. 1986 J. Biol. Chem. pmid:3007487
Narumiya S and Fukushima M Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. 1986 J. Pharmacol. Exp. Ther. pmid:3772804
Narumiya S et al. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. 1986 J. Pharmacol. Exp. Ther. pmid:3772805
Bregman MD et al. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. 1986 Cancer Res. pmid:3698005
Kato T et al. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo. 1986 Cancer Res. pmid:3708585
Zavoico GB et al. Regulation of intracellular pH in human platelets. Effects of thrombin, A23187, and ionomycin and evidence for activation of Na+/H+ exchange and its inhibition by amiloride analogs. 1986 J. Biol. Chem. pmid:3020026
Schleimer RP et al. Characterization of inflammatory mediator release from purified human lung mast cells. 1986 Am. Rev. Respir. Dis. pmid:3485946
Peters SP et al. The pharmacologic control of mediator release from human basophils and mast cells. 1986 Respiration pmid:3494282
Bhuyan BK et al. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. 1986 Cancer Res. pmid:3456266
Brooks DP et al. Role of brain prostaglandins in the control of vasopressin secretion in the conscious rat. 1986 Endocrinology pmid:3456303
Watanabe K et al. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3456602
Maclouf J et al. Development of a radioimmunoassay for prostaglandin D2 using an antiserum against 11-methoxime prostaglandin D2. 1986 Prostaglandins pmid:3456623
Barnes VF and Heavey DJ Effect of prostaglandin D2 on histamine-induced weals in human skin. 1986 Br. J. Pharmacol. pmid:3456816
Gaetani P et al. Prostaglandin D2 monitoring in human CSF after subarachnoid hemorrhage: the possible role of prostaglandin D2 in the genesis of cerebral vasospasm. 1986 Ital J Neurol Sci pmid:3456998
Sugiyama T et al. Platelet prostaglandin D2 dehydrogenase in patients with myeloproliferative disorders. 1986 Prostaglandins Leukot Med pmid:3457389
Omini C et al. Prostaglandin D2 (PGD2) potentiates cholinergic responsiveness in guinea-pig trachea. 1986 J Auton Pharmacol pmid:3464602
Kikuchi Y et al. Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. 1986 Cancer Res. pmid:3458525
Hamilton RG et al. Dirofilaria immitis: diethylcarbamazine-induced anaphylactoid reactions in infected dogs. 1986 Exp. Parasitol. pmid:3458592
Nakagawa Y et al. [Effect of prostaglandin D2 on the growth of mouse glioma]. 1986 Gan To Kagaku Ryoho pmid:3459395
Naclerio R et al. The role of inflammatory mediators in allergic rhinitis. 1986 Ear Nose Throat J pmid:3459645
Wogensen L and Warberg J Effect of prostaglandin D2 on the release of luteinizing hormone and prolactin in castrated and intact male rats. 1986 Acta Endocrinol. pmid:3461657
Ruzicka T et al. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. 1986 J. Invest. Dermatol. pmid:3018086
Kuno S et al. Prostaglandin E2 administered via anus causes immunosuppression in male but not female rats: a possible pathogenesis of acquired immune deficiency syndrome in homosexual males. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3458226
Inoué S Multifactorial humoral regulation of sleep. 1986 Clin Neuropharmacol pmid:3471328
Bhuyan BK et al. Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in culture. 1986 Invest New Drugs pmid:3473056
Dutta-Roy AK et al. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. 1986 Science pmid:3001935
Lumsden MA et al. Changes in the concentration of prostaglandins in preovulatory human follicles after administration of hCG. 1986 J. Reprod. Fertil. pmid:3459888